Abbvie Inc banner

Wall St Price Targets

ABBV Price Targets Summary
Abbvie Inc

Wall Street analysts forecast ABBV stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for ABBV is 206.92 CHF with a low forecast of 153.07 CHF and a high forecast of 277.8 CHF.

Lowest Forecast
Price Target
153.07 CHF
58% Upside
Average Forecast
Price Target
206.92 CHF
114% Upside
Highest Forecast
Price Target
277.8 CHF
187% Upside
Abbvie Inc Competitors:
Price Targets
WOOF
Petco Health and Wellness Company Inc
32% Upside
QXO
SilverSun Technologies Inc
76% Upside

Revenue
Forecast

9% / Year
Past Growth
5% / Year
Estimated Growth
Estimates Accuracy
-2%
Average Miss
9% / Year
Past Growth
5% / Year
Estimated Growth
Estimates Accuracy
-2%
Average Miss

Over the last 14 years, the compound annual growth rate for Revenue has been 9%. The projected CAGR for the next 8 years is 5%.

Operating Income
Forecast

12% / Year
Past Growth
11% / Year
Estimated Growth
Estimates Accuracy
-16%
Average Miss
12% / Year
Past Growth
11% / Year
Estimated Growth
Estimates Accuracy
-16%
Average Miss

Over the last 14 years, the compound annual growth rate for Operating Income has been 12%. The projected CAGR for the next 8 years is 11%.

Net Income
Forecast

1% / Year
Past Growth
32% / Year
Estimated Growth
Estimates Accuracy
-52%
Average Miss
1% / Year
Past Growth
32% / Year
Estimated Growth
Estimates Accuracy
-52%
Average Miss

Over the last 14 years, the compound annual growth rate for Net Income has been 1%. The projected CAGR for the next 8 years is 32%.

Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is ABBV's stock price target?
Price Target
206.92 CHF

According to Wall Street analysts, the average 1-year price target for ABBV is 206.92 CHF with a low forecast of 153.07 CHF and a high forecast of 277.8 CHF.

What is the Revenue forecast for Abbvie Inc?
Projected CAGR
5%

Over the last 14 years, the compound annual growth rate for Revenue has been 9%. The projected CAGR for the next 8 years is 5%.

What is the Operating Income forecast for Abbvie Inc?
Projected CAGR
11%

Over the last 14 years, the compound annual growth rate for Operating Income has been 12%. The projected CAGR for the next 8 years is 11%.

What is the Net Income forecast for Abbvie Inc?
Projected CAGR
32%

Over the last 14 years, the compound annual growth rate for Net Income has been 1%. The projected CAGR for the next 8 years is 32%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett